FDA Drug recall D-0453-2017
Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc
- FDA Drug
- Class III
- terminated
- Published 2017-02-08
On 2017-02-08 the FDA classified a Class III recall of Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc by Hetero Drugs Unit 1, citing failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0453-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-12-29 |
| Published | 2017-02-08 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hetero Drugs Unit 1 |
| Distribution | NJ |
Product
Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs, Unit V Polepally, Jadcheria, Mahaboob Nagar - 509 301, India Limited NDC 31722-525-90
Reason
Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.
Identifiers
| ndc | 31722-525-30 |
|---|---|
| ndc | 31722-525-01 |
| ndc | 31722-525-10 |
| ndc | 31722-525-90 |
| ndc | 31722-525-05 |
| code_info | Lot #: FIN16002, Exp. 03/2018 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0453-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.